Retraction: hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma
Erratum to: Ann Transl Med 2021;9:1242.
The paper “hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma” (doi: 10.21037/atm-21-3076) published in Annals of Translational Medicine in Vol 9, No 15 (August 13, 2021) (1) has been retracted at the request of the authors. While repeating some of the experiments in the paper for our subsequent project, we have obtained different results that would impact the conclusions drawn in the paper. In light of these new results, all the authors have decided to withdraw this article, as its publication will be misleading. All authors agree with the retraction of the paper. We are sorry for the inconvenience caused.
Footnote
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-2024-7/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Gao Y, Liu C, Zhao X, et al. hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma. Ann Transl Med 2021;9:1242. [Crossref] [PubMed]